In the latest session, Inogen Inc (NASDAQ: INGN) closed at $6.68 down -4.91% from its previous closing price of $7.03. In other words, the price has decreased by -$0.35 from its previous closing price. On the day, 610694 shares were traded.
Ratios:
For a deeper understanding of Inogen Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.55 and its Current Ratio is at 2.86. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
On August 08, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $15 to $8.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INGN now has a Market Capitalization of 163.85M and an Enterprise Value of 57.31M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.49 while its Price-to-Book (P/B) ratio in mrq is 0.76. Its current Enterprise Value per Revenue stands at 0.18 whereas that against EBITDA is -0.98.
Stock Price History:
Over the past 52 weeks, INGN has reached a high of $15.88, while it has fallen to a 52-week low of $4.13. The 50-Day Moving Average of the stock is 6.82, while the 200-Day Moving Average is calculated to be 7.13.
Shares Statistics:
For the past three months, INGN has traded an average of 633.51K shares per day and 796.91k over the past ten days. A total of 23.32M shares are outstanding, with a floating share count of 22.74M. Insiders hold about 2.46% of the company’s shares, while institutions hold 90.68% stake in the company. Shares short for INGN as of Feb 15, 2024 were 1.97M with a Short Ratio of 3.11, compared to 1.54M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.45% and a Short% of Float of 11.92%.
Earnings Estimates
There are 4 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.76 for the current quarter, with a high estimate of -$0.65 and a low estimate of -$0.85, while EPS last year was -$0.88. The consensus estimate for the next quarter is -$0.6, with high estimates of -$0.5 and low estimates of -$0.7.
Analysts are recommending an EPS of between -$2.31 and -$2.63 for the fiscal current year, implying an average EPS of -$2.5. EPS for the following year is -$1.96, with 4 analysts recommending between -$1.35 and -$2.3.
Revenue Estimates
A total of 4 analysts believe the company’s revenue will be $73.66M this quarter.It ranges from a high estimate of $74.5M to a low estimate of $73M. As of the current estimate, Inogen Inc’s year-ago sales were $72.16M, an estimated increase of 2.10% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $84.17M, an increase of 0.60% less than the figure of $2.10% in the same quarter last year. There is a high estimate of $88.1M for the next quarter, whereas the lowest estimate is $79M.
A total of 4 analysts have provided revenue estimates for INGN’s current fiscal year. The highest revenue estimate was $330.4M, while the lowest revenue estimate was $316M, resulting in an average revenue estimate of $323.45M. In the same quarter a year ago, actual revenue was $315.66M, up 2.50% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $338.42M in the next fiscal year. The high estimate is $345.3M and the low estimate is $332M. The average revenue growth estimate for next year is up 4.60% from the average revenue estimate for this year.
